Skip to main content
Print Page    E-mail Page    RSS    E-mail Alerts    Tearsheet 

Analyst Coverage

Canaccord GenuityJohn Newman
CantorMatt Lillis
Chardan Capital MarketsTaylor  Feehley
CowenChris Shibutani
Goldman SachsTerence Flynn
OppenheimerMark Breidenbach
Seres Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Seres Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Seres Therapeutics, Inc. or its management. Seres Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.